What is the current status of airway pressure release ventilation (APRV) in clinical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Current Status of APRV in Clinical Practice

APRV (Airway Pressure Release Ventilation) is not included in major evidence-based guidelines for ARDS management and lacks sufficient high-quality evidence to recommend its routine use, though emerging data suggests it may serve as a viable alternative ventilation strategy with potential benefits in early oxygenation and lung protection.

Guideline Position

The 2017 ATS/ERS/SCCM Clinical Practice Guidelines for mechanical ventilation in ARDS make no mention of APRV as a recommended ventilation strategy 1. This comprehensive guideline addresses:

  • Strong recommendations FOR: Low tidal volume ventilation (4-8 ml/kg PBW, plateau pressure <30 cm H2O) and prone positioning >12 hours/day in severe ARDS
  • Strong recommendations AGAINST: Routine high-frequency oscillatory ventilation (HFOV)
  • Conditional recommendations: Higher PEEP and recruitment maneuvers in moderate-severe ARDS

The absence of APRV from these guidelines reflects the historical lack of robust evidence at the time of guideline development.

Current Evidence Base

Most Recent Meta-Analysis (2026)

The highest quality recent evidence comes from a 2026 systematic review and meta-analysis of 9 studies with 1,921 patients 2. This study found:

Benefits:

  • Significantly improved early oxygenation (higher PaO2/FiO2 ratios on Days 1 and 3)
  • Shorter ICU length of stay
  • More ventilator-free days
  • Lower plateau pressures at Days 3 and 7 (suggesting lung-protective effects)

No difference in:

  • ICU or hospital mortality
  • Total ventilator duration
  • Overall hospital length of stay

Critical interpretation: APRV demonstrates physiologic advantages and improved ICU metrics without mortality benefit, positioning it as a reasonable alternative rather than a superior strategy.

Evolving Clinical Role

Paradigm Shift in Application

APRV has undergone a significant conceptual evolution 3, 4:

Historical use: Late rescue therapy for severe, refractory ARDS

Current trend: Early lung-protective ventilation strategy

The modern approach using Time-Controlled Adaptive Ventilation (TCAV) methodology focuses on:

  • Extended inspiratory time with brief expiratory releases
  • Progressive recruitment of collapsed lung over hours/days
  • Personalized release timing based on expiratory flow analysis (termination at 75% of peak expiratory flow)
  • Maintenance near functional residual capacity while promoting spontaneous breathing 4, 5

Practical Advantages

APRV offers several operational benefits that may explain increasing adoption despite limited guideline support 3, 6:

  • Reduced sedation requirements (allows spontaneous breathing)
  • Improved hemodynamic profiles
  • Potential for earlier mobilization
  • May avoid progression to ECMO in select cases 7

Critical Limitations and Caveats

Why APRV Remains Controversial

  1. Lack of standardization: Wide variability in APRV protocols between centers makes evidence synthesis difficult 6

  2. Insufficient mortality data: Despite physiologic benefits, no study has demonstrated mortality reduction—the most important patient-centered outcome 2

  3. Guideline exclusion: Major societies have not endorsed APRV, reflecting evidence gaps at guideline development 1

  4. Heterogeneous patient populations: Difficulty identifying which ARDS phenotypes benefit most 6

  5. Expertise requirement: APRV demands specialized knowledge and careful titration, limiting widespread implementation 5

Clinical Decision Framework

When to consider APRV:

  • Moderate-to-severe ARDS with refractory hypoxemia on conventional low tidal volume ventilation
  • High plateau pressures (>28-30 cm H2O) despite optimization
  • Desire to minimize sedation and promote spontaneous breathing
  • Institutional expertise with APRV/TCAV protocols available

When NOT to use APRV:

  • Mild ARDS responding to conventional ventilation
  • Lack of institutional experience/protocols
  • Obstructive lung disease (though emerging case series suggest possible role 7)
  • When guideline-recommended strategies (low tidal volume, prone positioning) have not been fully implemented

Practical approach:

  1. First-line: Implement proven strategies from guidelines—low tidal volume ventilation (4-8 ml/kg PBW), plateau pressure <30 cm H2O, prone positioning if severe ARDS 1
  2. Second-line: Optimize PEEP and consider recruitment maneuvers in moderate-severe ARDS 1
  3. Alternative strategy: Consider APRV if refractory hypoxemia persists AND institutional expertise exists, recognizing it as an alternative rather than superior approach 2

Bottom Line

APRV occupies an evolving niche in ARDS management—transitioning from rescue therapy to potential early lung-protective strategy. While 2026 meta-analysis data support its safety and physiologic benefits 2, the absence from major guidelines and lack of mortality benefit mean APRV should be viewed as an alternative ventilation mode rather than standard of care. Clinicians should prioritize guideline-recommended strategies first, reserving APRV for refractory cases at centers with established protocols and expertise. The field awaits large-scale RCTs with mortality endpoints to definitively establish APRV's role.

References

5
Research

Airway Pressure Release Ventilation: A Field Guide for the Emergency Physician.

Emergency medicine clinics of North America, 2022

Related Questions

When should Airway Pressure Release Ventilation (APRV) be used instead of Pressure Regulated Volume Control (PRVC), and what are the recommended ventilator settings for each mode?
Can Airway Pressure Release Ventilation (APRV) be used for weaning in a spontaneously breathing patient?
How do I adjust Airway Pressure Release Ventilation (APRV) settings for a patient?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What intravenous pain control regimen should be used in the hospital for an adult (~70 kg) patient experiencing a sickle cell vaso‑occlusive crisis?
What are the pathophysiology and mechanisms of death in refeeding syndrome?
In an 82‑year‑old patient on levothyroxine with a suppressed TSH, how should the dose be adjusted and what target TSH range is appropriate?
What is the appropriate treatment for seborrheic dermatitis around the eye?
How should a 40-year-old with a right traumatic tympanic membrane perforation (6 years ago) presenting with intermittent otorrhea, tinnitus, itching, and concurrent productive cough, sore throat, and rhinorrhea be managed?
Can non‑alcoholic wine be recommended to obtain the polyphenol‑related benefits of wine, and should it be used as a treatment for cardiovascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.